The Most Active Investors In Genomics https://t.co/Nx6pwGPfB9
— The Propell Group (@ThePropellGroup) August 20, 2017
#healthtech
The Most Active Investors In Genomics https://t.co/Nx6pwGPfB9
— The Propell Group (@ThePropellGroup) August 20, 2017
#healthtech